<DOC>
	<DOC>NCT00002429</DOC>
	<brief_summary>This study tests a new form of didanosine, ddI EC, a coated pill that passes through the stomach before dissolving. The purpose of this study is to compare the effectiveness of an anti-HIV drug combination that includes ddI EC versus another anti-HIV drug combination.</brief_summary>
	<brief_title>Evaluation of an Anti-HIV Drug Combination That Includes a Coated Form of Didanosine (ddI EC) Compared to a Typical Anti-HIV Drug Regimen</brief_title>
	<detailed_description>Patients are randomized to 1 of 2 groups for 48 weeks of open-label treatment. Group 1 receives ddI EC plus d4T plus NFV. Group 2 receives Combivir plus NFV. Antiviral activity is determined by the proportion of patients with HIV RNA levels of less than 400 copies/ml at Week 48.</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Nelfinavir</mesh_term>
	<mesh_term>Stavudine</mesh_term>
	<mesh_term>Didanosine</mesh_term>
	<mesh_term>Zidovudine</mesh_term>
	<mesh_term>Lamivudine</mesh_term>
	<mesh_term>Lamivudine, zidovudine drug combination</mesh_term>
	<criteria>Inclusion Criteria Patients may be eligible for this study if they: Are HIVpositive. Have a viral load of at least 2,000 copies/ml and a CD4 count of at least 200 cells/mm3. Are at least 18 years old. Agree to practice sexual abstinence or to use effective barrier methods of birth control (such as condoms). Exclusion Criteria Patients will not be eligible for this study if they: Have had severe diarrhea within 30 days of study entry. Have a history of pancreatic disease or any other serious condition. Have hepatitis within 30 days of study entry. Are diagnosed with an opportunistic (AIDSrelated) infection at the time of enrollment. Are unable to take medications by mouth. Have received certain medications. Are pregnant or breastfeeding.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2011</verification_date>
	<keyword>Didanosine</keyword>
	<keyword>Drug Therapy, Combination</keyword>
	<keyword>Stavudine</keyword>
	<keyword>RNA, Viral</keyword>
	<keyword>Nelfinavir</keyword>
	<keyword>Reverse Transcriptase Inhibitors</keyword>
	<keyword>Anti-HIV Agents</keyword>
</DOC>